Overview Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis Status: Not yet recruiting Trial end date: 2026-03-31 Target enrollment: Participant gender: Summary The study is designed to investigate efficacy and safety of CU104 in patients with moderate to severe ulcerative colitis. Phase: Phase 2 Details Lead Sponsor: Curacle Co., Ltd.